Lamictal Pregnancy Monitoring Will Continue Following “FDA Alert”
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA issues leaflet to physicians and healthcare professionals regarding potential oral clefts in children exposed to Lamictal during first trimester of pregnancy.